Novo CEO pressed by Senate to cut rates of weight problems, diabetes drugs CEO Lars Fruergaard Jørgensen instructed lawmakers the company would consider new talks with insurers regarding the list rates of Wegovy and copyright whenever they pledge to maintain the medicines on their formularies. Financial commitment in digital wellbeing https://kethek.com/